A detailed history of Fortitude Family Office, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 38 shares of GH stock, worth $3,586. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38
Previous 33 15.15%
Holding current value
$3,586
Previous $2.06 Million 88.22%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

BUY
$61.46 - $98.92 $307 - $494
5 Added 15.15%
38 $3.88 Million
Q3 2025

Oct 17, 2025

SELL
$40.98 - $67.42 $122 - $202
-3 Reduced 8.33%
33 $2.06 Million
Q2 2025

Jul 14, 2025

BUY
$37.05 - $52.04 $1,333 - $1,873
36 New
36 $1.87 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $9.65B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Fortitude Family Office, LLC Portfolio

Follow Fortitude Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Family Office, LLC with notifications on news.